...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: I would rather,...

"I would rather have aced the CKD and VD sub groups as we did and missed the CVD than vis-versa."

Are you sure about that?

Had we aced the CVD (assuming you mean BOM), we would be looking at a $20 stock today, and that would include the good data for CKD and VD subgroups as part of the overall CVOT trial. 

 

Koo

 

 

Share
New Message
Please login to post a reply